BSE · KOBO
KOBO BIOTECH LIMITED
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#4,617
of 5,085 stocks
▼ 1021W
Peak #4,515 · 21 Sep 2026
Operating in Healthcare, KOBO BIOTECH LIMITED has a subdued return on equity and has promoters holding 45%.
Market Cap
8.79 Cr
P/E Ratio
—
P/B Ratio
—
ROE
3.71%
ROCE
5.11%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2024-25 | Q4 2023-24 | Q3 2023-24 | Q2 2023-24 |
|---|---|---|---|---|
| Revenue | Rs 0 | Rs 0 | Rs 0 | Rs 0 |
| Net Profit | -1.33 Cr | -1.26 Cr | -1.23 Cr | -1.22 Cr |
| EPS | 0.00 | -0.53 | -0.52 | 0.00 |
| Operating Profit | -1.33 Cr | -1.26 Cr | -1.23 Cr | -1.22 Cr |
Shareholding pattern
Promoter
44.95%
Public
55.05%
PUBLIC BREAKDOWN
DII
0.00%
Individuals
46.51%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 21 Sep 2012 | Dividend | Dividend - Rs. - 1.0000 |
| 22 Jul 2011 | Dividend | Dividend - Rs. - 1.0000 |
| 23 Sep 2010 | Dividend | Dividend - Rs. - 1.0000 |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.